뒤로
Medigene AG(MDGEF) 가격
MDGEF 주가 차트
MDGEF 수입
Medigene AG
$2.59
0%
$0
종가: Jan 16, 16:00:00 GMT-5
$2.59
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$2.59
시가
$2.59
일일 범위
$0.1 - $2.59
52주 범위
$0.1 - $2.59
거래량
10.0K
평균 거래량
0
EPS(TTM)
-1.28
배당수익률
--
시가총액
$38.1M
MDGEF란 무엇인가요?
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. The company is headquartered in Planegg, Bayern and currently employs 86 full-time employees. The company went IPO on 2000-06-30. The firm focuses on the development of personalized T cell-based immunotherapies. The company develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The firm operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.